A preliminary study of (18)F-FES PET/CT in predicting metastatic breast cancer in patients receiving docetaxel or fulvestrant with docetaxel

The present explorative study was initiated to evaluate the clinical value of (18)F-FES PET/CT in monitoring the change of estrogen receptor (ER) expression and potential predictive value in metastatic breast cancer patients. Twenty-two pathology-confirmed breast cancer patients were prospectively e...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Gong, Chengcheng, Yang, Zhongyi, Sun, Yifei, Zhang, Jian, Zheng, Chunlei, Wang, Leiping, Zhang, Yongping, Xue, Jing, Yao, Zhifeng, Pan, Herong, Wang, Biyun, Zhang, Yingjian
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5529439/
https://ncbi.nlm.nih.gov/pubmed/28747642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-06903-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars